Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
6.75
-0.37
(-5.20%)
At close: February 28 at 4:00:00 PM EST
6.38
-0.37
(-5.48%)
After hours: February 28 at 5:52:01 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-142,655
-202,744
-245,343
76,901
137,738
Investing Cash Flow
55,912
-20,585
-29,054
-93,117
-19,340
Financing Cash Flow
72,216
63,081
215,116
154,504
21,740
End Cash Position
156,726
126,080
286,532
346,642
204,435
Capital Expenditure
-26,004
-14,312
-29,322
-93,171
-19,471
Issuance of Capital Stock
--
--
189,837
166,823
290
Issuance of Debt
--
81,111
39,331
859
50,266
Repayment of Debt
-8,138
-5,224
-4,841
-4,761
-24,106
Repurchase of Capital Stock
--
-240
--
--
--
Free Cash Flow
-168,659
-217,056
-274,665
-16,270
118,267
12/31/2020 - 5/5/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GNFT Genfit S.A.
3.4700
-1.98%
ZBIO Zenas BioPharma, Inc.
7.01
+6.05%
NBTX Nanobiotix S.A.
3.5100
-4.10%
ENTA Enanta Pharmaceuticals, Inc.
7.78
-1.27%
REPL Replimune Group, Inc.
12.68
+0.36%
SCPH scPharmaceuticals Inc.
3.2800
+1.23%
UPB Upstream Bio, Inc.
7.93
+1.54%
NURPF Neuren Pharmaceuticals Limited
8.60
0.00%
SEPN Septerna, Inc.
6.47
+11.55%
MGTX MeiraGTx Holdings plc
7.13
+2.15%